Reuters
24 Jun 2026, 14:51 UTC · 1h ago
Pfizer dismissed from US states' drug price-fixing lawsuit
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
24 Jun 2026, 14:51 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Pfizer has been dismissed as a defendant in a sweeping antitrust lawsuit involving generic drug price-fixing. — Removal of significant legal liability and potential multi-billion dollar settlement risks reduces the company's risk profile.
+0.40Which stocks this story touches
Pfizer was dismissed as a defendant in a major antitrust lawsuit regarding generic drug price fixing.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
13h ago
